PPA
SRRA

Parametric Portfolio Associates’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Parametric Portfolio Associates’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.4M Buy
+43,721
New +$1.25M ﹤0.01% 2609

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Parametric Portfolio Associates's SRRA Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022: 43,721 shares worth $1.4M. The stake represents ﹤0.01% of the portfolio and ranks #2609 among its holdings.

75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

  • Parametric Portfolio Associates held 43,721 shares of Sierra Oncology, Inc. Common Stock worth $1.4M as of Q1 2022.
  • Sierra Oncology, Inc. Common Stock was a new Parametric Portfolio Associates position in Q1 2022.
  • Sierra Oncology, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2609 holding.
  • 75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.